帕金森病患者出院后自我报告的不依从性预测药物变化

IF 2.1 4区 医学 Q3 CLINICAL NEUROLOGY
Parkinson's Disease Pub Date : 2020-07-04 eCollection Date: 2020-01-01 DOI:10.1155/2020/4315489
Francis Feldmann, Hannah M Zipprich, Otto W Witte, Tino Prell
{"title":"帕金森病患者出院后自我报告的不依从性预测药物变化","authors":"Francis Feldmann,&nbsp;Hannah M Zipprich,&nbsp;Otto W Witte,&nbsp;Tino Prell","doi":"10.1155/2020/4315489","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Medication is often changed after hospital discharge in people with Parkinson's disease (PD).</p><p><strong>Objective: </strong>This observational study aimed to describe changes in PD medication after discharge and explore their association with self-reported adherence and clinical parameters.</p><p><strong>Methods: </strong>During hospitalisation sociodemographic characteristics, the Movement Disorder Society-sponsored revision of the Unified PD Rating Scale for motor function (MDS-UPDRS III), Hoehn and Yahr (H&Y) stage, levodopa equivalent daily dose (LEDD), Beck Depression Inventory II (BDI-II) score, Montreal Cognitive Assessment (MoCA) score, nonmotor symptoms questionnaire (NMSQ), and Stendal Adherence to Medication Score (SAMS) were collected in 125 people with PD. A semistructured interview was conducted 1 month after discharge to determine the extent and reasons for medication changes.</p><p><strong>Results: </strong>Thirty-eight patients (30.4%) changed their PD medication after discharge. Most changes (20.8%) were performed by physicians while 9.6% of patients changed their medication by themselves due to side effects, missing effect of the medication, missing knowledge about the indication, running out of medication, or nonspecific reason. This led to decreased doses while changes by physicians resulted in both increase and decrease of doses as well as new drug prescription. Patients without changes, patients with changes performed by them, and patients with changes performed by physicians did not differ in age, disease duration, MDS-UPDRS III, LEDD, NMSQ, MoCA, BDI-II, gender, marital status, or education. However, patients who themselves made the changes were more likely to be nonadherent according to baseline SAMS. Patients who made changes after discharge had higher SAMS modification and forgetting subscores than patients without changes or with changes made by physicians.</p><p><strong>Conclusion: </strong>Both intended and unintended nonadherence occur in patients who change medication after discharge. The use of an adherence questionnaire during inpatient treatment may help detect patients with higher risk of changing medication after discharge.</p>","PeriodicalId":19907,"journal":{"name":"Parkinson's Disease","volume":"2020 ","pages":"4315489"},"PeriodicalIF":2.1000,"publicationDate":"2020-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/4315489","citationCount":"9","resultStr":"{\"title\":\"Self-Reported Nonadherence Predicts Changes of Medication after Discharge from Hospital in People with Parkinson's Disease.\",\"authors\":\"Francis Feldmann,&nbsp;Hannah M Zipprich,&nbsp;Otto W Witte,&nbsp;Tino Prell\",\"doi\":\"10.1155/2020/4315489\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Medication is often changed after hospital discharge in people with Parkinson's disease (PD).</p><p><strong>Objective: </strong>This observational study aimed to describe changes in PD medication after discharge and explore their association with self-reported adherence and clinical parameters.</p><p><strong>Methods: </strong>During hospitalisation sociodemographic characteristics, the Movement Disorder Society-sponsored revision of the Unified PD Rating Scale for motor function (MDS-UPDRS III), Hoehn and Yahr (H&Y) stage, levodopa equivalent daily dose (LEDD), Beck Depression Inventory II (BDI-II) score, Montreal Cognitive Assessment (MoCA) score, nonmotor symptoms questionnaire (NMSQ), and Stendal Adherence to Medication Score (SAMS) were collected in 125 people with PD. A semistructured interview was conducted 1 month after discharge to determine the extent and reasons for medication changes.</p><p><strong>Results: </strong>Thirty-eight patients (30.4%) changed their PD medication after discharge. Most changes (20.8%) were performed by physicians while 9.6% of patients changed their medication by themselves due to side effects, missing effect of the medication, missing knowledge about the indication, running out of medication, or nonspecific reason. This led to decreased doses while changes by physicians resulted in both increase and decrease of doses as well as new drug prescription. Patients without changes, patients with changes performed by them, and patients with changes performed by physicians did not differ in age, disease duration, MDS-UPDRS III, LEDD, NMSQ, MoCA, BDI-II, gender, marital status, or education. However, patients who themselves made the changes were more likely to be nonadherent according to baseline SAMS. Patients who made changes after discharge had higher SAMS modification and forgetting subscores than patients without changes or with changes made by physicians.</p><p><strong>Conclusion: </strong>Both intended and unintended nonadherence occur in patients who change medication after discharge. The use of an adherence questionnaire during inpatient treatment may help detect patients with higher risk of changing medication after discharge.</p>\",\"PeriodicalId\":19907,\"journal\":{\"name\":\"Parkinson's Disease\",\"volume\":\"2020 \",\"pages\":\"4315489\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2020-07-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1155/2020/4315489\",\"citationCount\":\"9\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Parkinson's Disease\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1155/2020/4315489\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2020/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Parkinson's Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1155/2020/4315489","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 9

摘要

背景:帕金森病(PD)患者出院后经常更换药物。目的:本观察性研究旨在描述PD出院后用药的变化,并探讨其与自我报告依从性和临床参数的关系。方法:在住院期间,收集125名PD患者的社会人口学特征,包括运动障碍学会发起的运动功能统一PD评定量表(MDS-UPDRS III)、Hoehn和Yahr (H&Y)分期、左旋多巴当量日剂量(LEDD)、贝克抑郁量表II (BDI-II)评分、蒙特利尔认知评估(MoCA)评分、非运动症状问卷(NMSQ)和斯坦德药物依从性评分(SAMS)。出院1个月后进行半结构化访谈,以确定药物变化的程度和原因。结果:38例(30.4%)患者出院后改变PD药物治疗。大部分(20.8%)患者是由医生自行更换药物,而9.6%的患者是由于药物副作用、药效缺失、不了解适应症、药物用完或非特异性原因自行更换药物。这导致了剂量的减少,而医生的改变导致了剂量的增加和减少,以及新的药物处方。没有改变的患者、由他们进行改变的患者和由医生进行改变的患者在年龄、病程、MDS-UPDRS III、LEDD、NMSQ、MoCA、BDI-II、性别、婚姻状况或教育程度方面没有差异。然而,根据基线SAMS,自己做出改变的患者更有可能不坚持。出院后做出改变的患者的SAMS修改和遗忘评分高于未做改变或医生做出改变的患者。结论:出院后改换药物的患者均存在有意或无意的不依从。在住院治疗期间使用依从性问卷可能有助于发现出院后更换药物风险较高的患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Self-Reported Nonadherence Predicts Changes of Medication after Discharge from Hospital in People with Parkinson's Disease.

Self-Reported Nonadherence Predicts Changes of Medication after Discharge from Hospital in People with Parkinson's Disease.

Self-Reported Nonadherence Predicts Changes of Medication after Discharge from Hospital in People with Parkinson's Disease.

Self-Reported Nonadherence Predicts Changes of Medication after Discharge from Hospital in People with Parkinson's Disease.

Background: Medication is often changed after hospital discharge in people with Parkinson's disease (PD).

Objective: This observational study aimed to describe changes in PD medication after discharge and explore their association with self-reported adherence and clinical parameters.

Methods: During hospitalisation sociodemographic characteristics, the Movement Disorder Society-sponsored revision of the Unified PD Rating Scale for motor function (MDS-UPDRS III), Hoehn and Yahr (H&Y) stage, levodopa equivalent daily dose (LEDD), Beck Depression Inventory II (BDI-II) score, Montreal Cognitive Assessment (MoCA) score, nonmotor symptoms questionnaire (NMSQ), and Stendal Adherence to Medication Score (SAMS) were collected in 125 people with PD. A semistructured interview was conducted 1 month after discharge to determine the extent and reasons for medication changes.

Results: Thirty-eight patients (30.4%) changed their PD medication after discharge. Most changes (20.8%) were performed by physicians while 9.6% of patients changed their medication by themselves due to side effects, missing effect of the medication, missing knowledge about the indication, running out of medication, or nonspecific reason. This led to decreased doses while changes by physicians resulted in both increase and decrease of doses as well as new drug prescription. Patients without changes, patients with changes performed by them, and patients with changes performed by physicians did not differ in age, disease duration, MDS-UPDRS III, LEDD, NMSQ, MoCA, BDI-II, gender, marital status, or education. However, patients who themselves made the changes were more likely to be nonadherent according to baseline SAMS. Patients who made changes after discharge had higher SAMS modification and forgetting subscores than patients without changes or with changes made by physicians.

Conclusion: Both intended and unintended nonadherence occur in patients who change medication after discharge. The use of an adherence questionnaire during inpatient treatment may help detect patients with higher risk of changing medication after discharge.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Parkinson's Disease
Parkinson's Disease CLINICAL NEUROLOGY-
CiteScore
5.80
自引率
3.10%
发文量
0
审稿时长
18 weeks
期刊介绍: Parkinson’s Disease is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies related to the epidemiology, etiology, pathogenesis, genetics, cellular, molecular and neurophysiology, as well as the diagnosis and treatment of Parkinson’s disease.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信